| Product Code: ETC9974984 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Rare Disease Genetic Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Rare Disease Genetic Testing Market - Industry Life Cycle |
3.4 United States (US) Rare Disease Genetic Testing Market - Porter's Five Forces |
3.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Specialty, 2021 & 2031F |
3.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United States (US) Rare Disease Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of rare diseases |
4.2.2 Technological advancements in genetic testing |
4.2.3 Rising demand for personalized medicine |
4.3 Market Restraints |
4.3.1 High cost of genetic testing |
4.3.2 Limited insurance coverage for rare disease testing |
4.3.3 Regulatory hurdles and approval processes |
5 United States (US) Rare Disease Genetic Testing Market Trends |
6 United States (US) Rare Disease Genetic Testing Market, By Types |
6.1 United States (US) Rare Disease Genetic Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.1.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.1.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Hematology Diseases, 2021- 2031F |
6.1.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Endocrine & Metabolism Diseases, 2021- 2031F |
6.1.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Musculoskeletal Disorders, 2021- 2031F |
6.1.9 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F |
6.1.10 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F |
6.2 United States (US) Rare Disease Genetic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.2.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.2.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Array Technology, 2021- 2031F |
6.2.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By PCR-based Testing, 2021- 2031F |
6.2.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By FISH, 2021- 2031F |
6.2.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.2.9 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.3 United States (US) Rare Disease Genetic Testing Market, By Specialty |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Molecular Genetic Tests, 2021- 2031F |
6.3.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Chromosomal Genetic Tests, 2021- 2031F |
6.3.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Biochemical Genetic Tests, 2021- 2031F |
6.4 United States (US) Rare Disease Genetic Testing Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Research Laboratories & CROs, 2021- 2031F |
6.4.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
7 United States (US) Rare Disease Genetic Testing Market Import-Export Trade Statistics |
7.1 United States (US) Rare Disease Genetic Testing Market Export to Major Countries |
7.2 United States (US) Rare Disease Genetic Testing Market Imports from Major Countries |
8 United States (US) Rare Disease Genetic Testing Market Key Performance Indicators |
8.1 Number of newly diagnosed rare disease cases |
8.2 Adoption rate of genetic testing technologies |
8.3 Investment in research and development for rare disease treatments |
9 United States (US) Rare Disease Genetic Testing Market - Opportunity Assessment |
9.1 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Specialty, 2021 & 2031F |
9.4 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United States (US) Rare Disease Genetic Testing Market - Competitive Landscape |
10.1 United States (US) Rare Disease Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Rare Disease Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here